![Für diesen Artikel ist leider kein Bild verfügbar.](/img/platzhalter480px.png)
Asthma
Clinical Publishing,an imprint of Atlas Medical Publishing Ltd (Verlag)
978-1-84692-015-8 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
As the incidence of asthma in the adult population continues to increase, and the age of onset in children to decrease, this condition remains a primary concern not only for specialists in respiratory medicine, but also for physicians in many other fields, when dealing with the asthmatic patient. The range of therapeutic agents now available, and the diversity of targets on which they act, presents the doctor with a variety of options for managing the condition. In this volume, leading international authorities explain the mechanisms of action of the drugs currently in use, and their clinical applications, singly and in combination. "Asthma: Current Treatments" provides physicians with a comprehensive resource that will help them evaluate for themselves the right approach for each of their patients. It will also be of interest to other health professionals involved in the care of patients being treated for this condition.
R Polosa, Presidio Ospedaliero Ascoli-Tomaselli, Catania, Italy ST Holgate, Southampton General Hospital, Southampton, UK
Preface; FIRST LINE ANTI-INFLAMMATORY AND BRONCHODILATOR DRUGS; 1. Novel mechanistic aspects of GCS in relation to asthma therapy. I Adcock; 2. Benefit-risk of long-acting [beta]-adrenergic and ultra long-acting [beta]-adrenergic agonists. M Cazzola, J Lotvall, MG Matera; 3. Non-bronchodilator activities of beta2-agonists: enhanced efficacy in the management of asthma? N Hanania; 4. The pros and cons of combination therapy. J Lotvall; NOVEL APPROACHES TO BRONCHODILATION; 5. Controversies on antileukotrienes. S Salvi; 6. Role of PDE4 in asthma. G Currie; 7. Anti-cholinergics in asthma? C Virchow; IMMUNOMODULATION; 8. The new role of anti-IgE therapy in the treatment of asthma. C Oliveri, R Polosa, G D'Amato; 9. Life, death and resurrection of allergen immunotherapy in asthma. R Polosa; 10. Role of CpG DNA in asthma. D Gor, J Kline; 11. Putative role of antimicrobial activity in asthma treatment. P Tarsia, S Aliberti, M Pappalettera, M Zanardelli, F Blasi; SUBPHENOTYPE CENTERED THERAPY; 12. What is new in the management of acute asthma? GJ Rodrigo; 13. Rethinking individualized treatment of asthma. FE Hargreave; 14. Determinants of therapeutic response in asthma: cigarette smoking. M Spears, R Chaudhuri, NC Thomson; Abbreviations; General Index.
Erscheint lt. Verlag | 25.1.2007 |
---|---|
Reihe/Serie | Therapeutic Strategies in ... |
Zusatzinfo | diagrams, charts, tables |
Verlagsort | Oxford |
Sprache | englisch |
Maße | 170 x 240 mm |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Pneumologie |
ISBN-10 | 1-84692-015-9 / 1846920159 |
ISBN-13 | 978-1-84692-015-8 / 9781846920158 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich